Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by van Rooij, W.J. Articles by Beute, G.N. Search for Related Content PubMed PubMed Citation Articles by van Rooij, W.J. Articles by Beute, G.N.

American Journal of Neuroradiology 28:172-177, January 2007
© 2007 American Society of Neuroradiology

INTERVENTIONAL

Brain AVM Embolization with Onyx

W.J. van Rooij^a, M. Sluzewski^a and G.N. Beute^b

^a Department of Radiology, St. Elisabeth Ziekenhuis, Tilburg, The Netherlands
^b Department of Neurosurgery and Radiosurgery, St. Elisabeth Ziekenhuis, Tilburg, The Netherlands

Address correspondence to Willem Jan van Rooij, MD, PhD, Department of Radiology, St. Elisabeth Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, The Netherlands; e-mail: radiol{at}knmg.nl

BACKGROUND AND PURPOSE: To report the initial experience by using a new liquid embolic agent (Onyx) for embolization of brain arteriovenous malformations (AVMs).

METHODS: Between May 2000 and December 2005, 44 patients with brain AVMs were embolized with Onyx. There were 18 women and 26 men with a mean age of 42.4 years (median 44, range 14–71 years). Clinical presentation included seizures in 26 patients (59%), hemorrhage from the AVM in 13 patients (30%), subarachnoid hemorrhage from a concomitant aneurysm in 3 patients (7%), visual disturbances in 1 patient (2.3%), and in 1 patient (2.3%) the AVM was an incidental finding. Mean estimated size of the AVM was 3.9 cm (median 4, range 2–7 cm).

RESULTS: In 44 patients, 52 embolization procedures were performed with 138 feeding pedicles embolized, ranging from 1 to 7 per patient. Average estimated size reduction was 75% (median 80%, range 40%–100%). Total obliteration was achieved in 7 AVMs (16%), and partial embolization was followed by surgery in 10 patients and by radiosurgery in 20 patients. Complications occurred in 6 patients, leading to death in 1 patient (mortality 2.3%) and to permanent disability in 2 patients (morbidity 4.6%).

CONCLUSION: Onyx is feasible and safe in the embolization of brain AVMs. Complete obliteration can be achieved in small AVMs. Large AVMs can be adequately reduced in size for additional surgical or radiosurgical treatment.

This article has been cited by other articles:

				R.G. Nogueira, G. Dabus, J.D. Rabinov, C.J. Eskey, C.S. Ogilvy, J.A. Hirsch, and J.C. Pryor Preliminary Experience with Onyx Embolization for the Treatment of Intracranial Dural Arteriovenous Fistulas AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 91 - 97. [Abstract] [Full Text] [PDF]

				H. M. Do Comments on Brain AVM Embolization with Onyx AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 178 - 178. [Full Text] [PDF]